| 发明名称 |
5T4 tumour-associated antigen for use in tumour immunotherapy |
| 摘要 |
The present invention provides 5T4 tumour-associated antigen (TAA) for use in a method of immunotherapy of tumours. The invention also relates to a recombinant poxvirus vector from which at least one immune evasion gene has been deleted, which comprises a nucleic acid sequence encoding a 5T4 TAA and the use thereof in vaccinating against and in treating tumours.
|
| 申请公布号 |
EP2042598(A1) |
申请公布日期 |
2009.04.01 |
| 申请号 |
EP20090000205 |
申请日期 |
1999.11.18 |
| 申请人 |
OXFORD BIOMEDICA (UK) LIMITED |
发明人 |
CARROLL, MILES WILLIAM;MYERS, KEVIN ALAN |
| 分类号 |
C12N15/09;C12N15/12;A61K38/00;A61K38/17;A61K39/00;A61K39/275;A61K48/00;A61P15/00;A61P35/00;C07K7/06;C07K14/065;C07K14/47;C07K14/82;C07K19/00;C12N15/863 |
主分类号 |
C12N15/09 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
